Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
BioCardia, Inc. (NASDAQ:BCDA) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. BioCardia, Inc.'s stock currently trades…
Read morePrime Medicine, Inc. (NASDAQ:PRME) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Prime Medicine, Inc.'s stock…
Read moreByrna Technologies Inc. (NASDAQ:BYRN) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Byrna Technologies Inc.'s stock…
Read moreAptera Motors Corp (NASDAQ:SEV) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Aptera Motors Corp's stock currently…
Read moreHepion Pharmaceuticals, Inc. (NASDAQ:HEPA) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Hepion Pharmaceuticals,…
Read moreCompass Diversified Holdings (NYSE:CODI) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Compass Diversified…
Read moreADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. ADIAL PHARMACEUTICALS,…
Read moreInnventure, Inc. (NASDAQ:INV) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Innventure, Inc.'s stock currently…
Read moreOxford Square Capital Corp. (NASDAQ:OXSQ) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Oxford Square Capital…
Read moreEmergent BioSolutions Inc. (NYSE:EBS) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Emergent BioSolutions Inc.'s…
Read moreAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported…
Read moreSHF Holdings, Inc. (NASDAQ:SHFS) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. SHF Holdings, Inc.'s stock currently…
Read morePassage BIO, Inc. (NASDAQ:PASG) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual revenue…
Read moreAtara Biotherapeutics, Inc. (NASDAQ:ATRA) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Atara Biotherapeutics,…
Read moreScholar Rock Holding Corp (NASDAQ:SRRK) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual…
Read moreTheravance Biopharma, Inc. (NASDAQ:TBPH) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Theravance Biopharma, Inc.'s…
Read moreOFS Capital Corp (NASDAQ:OFS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Financial Services company reported annual…
Read morePEDEVCO CORP (AMEX:PED) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. PEDEVCO CORP's stock currently trades at $0.70…
Read morePrime Medicine, Inc. (NASDAQ:PRME) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual…
Read moreWEST BANCORPORATION INC (NASDAQ:WTBA) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 03, 2026. The Financial Services company's…
Read more
